JP2023541087A5 - - Google Patents
Info
- Publication number
- JP2023541087A5 JP2023541087A5 JP2022571252A JP2022571252A JP2023541087A5 JP 2023541087 A5 JP2023541087 A5 JP 2023541087A5 JP 2022571252 A JP2022571252 A JP 2022571252A JP 2022571252 A JP2022571252 A JP 2022571252A JP 2023541087 A5 JP2023541087 A5 JP 2023541087A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- seq
- drug
- pharmaceutical composition
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20315243.4 | 2020-05-18 | ||
| EP20315243.4A EP3912991A1 (en) | 2020-05-18 | 2020-05-18 | Therapeutic potential of peptides from the "netrin-like" domain of the frzb protein |
| PCT/EP2021/063109 WO2021233896A1 (en) | 2020-05-18 | 2021-05-18 | Therapeutic potential of peptides from the "netrin-like" domain of the frzb protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023541087A JP2023541087A (ja) | 2023-09-28 |
| JP2023541087A5 true JP2023541087A5 (https=) | 2024-05-28 |
Family
ID=71607831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022571252A Pending JP2023541087A (ja) | 2020-05-18 | 2021-05-18 | Ｆｒｚｂタンパク質の「ネトリン様」ドメインに由来するペプチドの治療可能性 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230183303A1 (https=) |
| EP (2) | EP3912991A1 (https=) |
| JP (1) | JP2023541087A (https=) |
| CN (1) | CN115996944A (https=) |
| CA (1) | CA3178537A1 (https=) |
| WO (1) | WO2021233896A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202401058D0 (en) * | 2024-01-26 | 2024-03-13 | Univ London Queen Mary | Treatment |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040031072A1 (en) * | 1999-05-06 | 2004-02-12 | La Rosa Thomas J. | Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement |
| EP1498133A1 (en) * | 2003-07-18 | 2005-01-19 | Aventis Pharma Deutschland GmbH | Use of a pak inhibitor for the treatment of a joint disease |
| WO2005070448A2 (en) * | 2004-01-21 | 2005-08-04 | Five Prime Therapeutics, Inc. | Methods of use for secreted frizzled-related protein 3 (sfrp-3) in the prevention and treatment of disease |
| WO2015176066A2 (en) * | 2014-05-16 | 2015-11-19 | Intermune, Inc. | Lpa-associated protein and rna expression |
| JP5967685B1 (ja) * | 2016-01-13 | 2016-08-10 | 国立大学法人名古屋大学 | 軟骨細胞のＷｎｔ／β−カテニンシグナル伝達経路の活性化抑制組成物及び変形性関節症治療用医薬組成物 |
| FR3051192B1 (fr) | 2016-05-13 | 2020-12-25 | Univ De Lorraine | Methode de purification de proteines recombinantes par affinite basee sur l'activite lectinique du domaine crd d'une galectine |
-
2020
- 2020-05-18 EP EP20315243.4A patent/EP3912991A1/en not_active Withdrawn
-
2021
- 2021-05-18 CA CA3178537A patent/CA3178537A1/en active Pending
- 2021-05-18 US US17/924,986 patent/US20230183303A1/en active Pending
- 2021-05-18 WO PCT/EP2021/063109 patent/WO2021233896A1/en not_active Ceased
- 2021-05-18 EP EP21725546.2A patent/EP4153611A1/en active Pending
- 2021-05-18 JP JP2022571252A patent/JP2023541087A/ja active Pending
- 2021-05-18 CN CN202180035631.5A patent/CN115996944A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022514255A5 (https=) | ||
| JP2020023567A5 (https=) | ||
| JP2007526248A5 (https=) | ||
| JPWO2019107530A5 (https=) | ||
| JP2019533722A5 (https=) | ||
| JP2022512478A5 (https=) | ||
| CY1113948T1 (el) | Θεραπευτικα δραστικα αλφα-msh αναλογα | |
| JP2011502964A5 (https=) | ||
| JP2008506709A5 (https=) | ||
| HRP20041108B1 (hr) | Peptidi povezani sa tumorom koji se vežu na mhc molekule | |
| JP2010536714A5 (https=) | ||
| JP2005516885A5 (https=) | ||
| JP2006514104A5 (https=) | ||
| JP2011518179A5 (https=) | ||
| JP2013533273A5 (https=) | ||
| WO2018067217A3 (en) | COMPOSITIONS COMPRISING SHORT PEPTIDES DERIVED FROM PEDF AND USES THEREOF | |
| CN110799522A (zh) | 用于治疗、改善或预防脑出血的肽及其用途 | |
| JP2012530060A5 (https=) | ||
| JPWO2019156137A5 (https=) | ||
| JP2006506942A5 (https=) | ||
| JP2009516654A5 (https=) | ||
| CA2529604A1 (en) | Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form | |
| JP2023541087A5 (https=) | ||
| JP2020117504A5 (https=) | ||
| JP2005502663A5 (https=) |